- Report
- October 2022
- 227 Pages
Global
From €3185EUR$3,600USD£2,730GBP
- Report
- October 2022
- 250 Pages
Global
From €3185EUR$3,600USD£2,730GBP
- Report
- October 2022
- 85 Pages
Europe
From €1327EUR$1,500USD£1,137GBP
- Report
- January 2025
- 159 Pages
Global
From €3500EUR$4,237USD£3,104GBP
- Report
- April 2025
- 170 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- January 2025
- 93 Pages
Global
From €3500EUR$4,237USD£3,104GBP
- Report
- January 2025
- 85 Pages
Global
From €3500EUR$4,237USD£3,104GBP
- Report
- February 2026
- 150 Pages
Canada
From €4291EUR$4,850USD£3,677GBP
- Report
- February 2026
- 150 Pages
India
From €4291EUR$4,850USD£3,677GBP
- Report
- March 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- March 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- March 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- December 2024
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- November 2024
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- July 2024
- 110 Pages
Global
From €2610EUR$2,950USD£2,237GBP
- Report
- July 2024
- 221 Pages
Global
From €4380EUR$4,950USD£3,753GBP
- Report
- September 2023
- 96 Pages
Global
From €3500EUR$4,237USD£3,104GBP
- Report
- February 2026
- 95 Pages
Global
From €3500EUR$4,237USD£3,104GBP

The biochemicals market is a subset of the biotechnology industry, focusing on the production and sale of chemicals used in research and development. These chemicals are used in a variety of applications, including drug discovery, diagnostics, and medical treatments. The biochemicals market is driven by the increasing demand for new and improved treatments for diseases, as well as the need for more efficient and cost-effective research and development processes.
The biochemicals market is highly competitive, with a wide range of companies offering products and services. Major players in the market include Sigma-Aldrich, Merck KGaA, Thermo Fisher Scientific, Bio-Rad Laboratories, and Lonza Group. Other companies in the market include Abcam, Cell Signaling Technology, Promega Corporation, and Bio-Techne Corporation. Show Less Read more